Drug Trial Radar · NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Last checked: Nov 19, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
2,500
Planned (sponsor's estimate)
Start
Aug 19, 2026
Primary completion
Aug 11, 2028
Study completion May 21, 2029
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 25, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment
Conditions
- Obesity or Overweight
Interventions
LenbelintideDrug
IMP injected subcutaneously, once a week. Unit dose strength as per CSP.
PlaceboDrug
Placebo matching IMP dose injected subcutaneously, once a week.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in body weight from baseline at 68 weeks of treatmentTime frame: 68 weeks
Locations
220 sites in 16 countries. Site status is shown where the registry gives one.
Research Site
Dothan, Alabama · Recruiting
Research Site
Huntsville, Alabama · Not yet recruiting
Research Site
Mesa, Arizona · Not yet recruiting
Research Site
Escondido, California · Recruiting
Research Site
Bridgeport, Connecticut · Not yet recruiting
Research Site
Clearwater, Florida · Recruiting
Research Site
Jacksonville, Florida · Not yet recruiting
Research Site
Stockbridge, Georgia · Recruiting
Research Site
Champaign, Illinois · Recruiting
Research Site
Chicago, Illinois · Recruiting
Research Site
Ames, Iowa · Recruiting
Research Site
El Dorado, Kansas · Not yet recruiting
Research Site
Owensboro, Kentucky · Not yet recruiting
Research Site
Troy, Michigan · Not yet recruiting
Research Site
Jefferson City, Missouri · Not yet recruiting
Research Site
Kansas City, Missouri · Recruiting
Research Site
Butte, Montana · Not yet recruiting
Research Site
Las Vegas, Nevada · Not yet recruiting
Research Site
Jersey City, New Jersey · Not yet recruiting
Research Site
Cortland, New York · Not yet recruiting
Research Site
Rochester, New York · Not yet recruiting
Research Site
Rocky Mount, North Carolina · Recruiting
Research Site
Statesville, North Carolina · Recruiting
Research Site
Wilmington, North Carolina · Not yet recruiting
Research Site
Fargo, North Dakota · Recruiting
Research Site
Columbus, Ohio · Recruiting
Research Site
Maumee, Ohio · Not yet recruiting
Research Site
Tulsa, Oklahoma · Recruiting
Research Site
Portland, Oregon · Not yet recruiting
Research Site
Philadelphia, Pennsylvania · Recruiting
Research Site
Smithfield, Pennsylvania · Recruiting
Research Site
Kingsport, Tennessee · Recruiting
Research Site
Memphis, Tennessee · Not yet recruiting
Research Site
Houston, Texas · Recruiting
Research Site
San Antonio, Texas · Not yet recruiting
Research Site
Sugar Land, Texas · Recruiting
Research Site
Waco, Texas · Recruiting
Research Site
Salt Lake City, Utah · Not yet recruiting
Research Site
Arlington, Virginia · Not yet recruiting
Research Site
Renton, Washington · Withdrawn
Showing 40 of 220 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.